{"node": "Post-myocardial infarction care and counseling", "content": "Management and counseling of patients after myocardial infarction (MI)", "children": [{"node": "A", "content": "History", "children": [{"node": "A1", "content": "STEMI vs. NSTEMI"}, {"node": "A2", "content": "Treatment (PCI, CABG, conservative)"}, {"node": "A3", "content": "In-hospital complications"}, {"node": "A4", "content": "Symptoms of angina, PVD, CVD, CHF"}, {"node": "A5", "content": "Tobacco use"}, {"node": "A6", "content": "Palpitations, syncope"}]}, {"node": "B", "content": "Examination", "children": [{"node": "B1", "content": "Signs/symptoms of CHF/LV dysfunction"}, {"node": "B2", "content": "Signs/symptoms of PVD, CVD"}, {"node": "B3", "content": "Weight/BMI"}, {"node": "B4", "content": "Waist circumference"}]}, {"node": "C", "content": "Laboratory testing", "children": [{"node": "C1", "content": "Renal function"}, {"node": "C2", "content": "Fasting lipids"}, {"node": "C3", "content": "Screening for diabetes mellitus"}, {"node": "C4", "content": "Hgb A1c if diabetic"}]}, {"node": "D", "content": "Testing", "children": [{"node": "D1", "content": "ECG"}, {"node": "D2", "content": "Echocardiogram (ECHO)"}, {"node": "D3", "content": "Stress testing"}, {"node": "D4", "content": "Submaximal exercise tolerance test (ETT) prior to hospital discharge if conservative management or consider if PCI and significant residual disease"}]}, {"node": "E", "content": "Risk assessment", "children": [{"node": "E1", "content": "Recurrent symptoms in unstable pattern", "children": [{"node": "E1.1", "content": "Refer for acute care"}]}, {"node": "E2", "content": "High-risk findings", "children": [{"node": "E2.1", "content": "High-risk stress test"}, {"node": "E2.2", "content": "Moderate to severe anginal symptoms"}, {"node": "E2.3", "content": "LV dysfunction ECHO"}, {"node": "E2.4", "content": "Signs/symptoms of CHF"}, {"node": "E2.5", "content": "Syncope/presyncope"}, {"node": "E2.6", "content": "Consider referral to cardiology for further diagnostic/invasive interventions"}]}]}, {"node": "F", "content": "Education", "children": [{"node": "F1", "content": "Patient", "children": [{"node": "F1.1", "content": "Importance of diet and exercise"}, {"node": "F1.2", "content": "Acute cardiac symptoms and how to find care"}, {"node": "F1.3", "content": "Avoidance of potentially harmful medications"}, {"node": "F1.4", "content": "Use of nitrates"}]}, {"node": "F2", "content": "Family", "children": [{"node": "F2.1", "content": "Acute cardiac symptoms and how to find care"}, {"node": "F2.2", "content": "Stress importance of lifestyle changes"}, {"node": "F2.3", "content": "CPR and AED education"}]}]}, {"node": "Treatment", "content": "Treatment", "children": [{"node": "G", "content": "Pharmacologic", "children": [{"node": "G1", "content": "Lipid lowering: NCEP guidelines, Goal LDL \u226470 mg/dl, Statins preferred"}, {"node": "G2", "content": "Antiplatelet therapy: ASA 75-162 mg lifetime, clopidogrel x 9-12 mo"}, {"node": "G3", "content": "Beta blockers: All post-MI patients unless contraindicated"}, {"node": "G4", "content": "Antihypertensive therapy: Goal per JNC 7"}, {"node": "G5", "content": "ACE inhibitor/ARB: If heart failure, LV dysfunction, or diabetes"}, {"node": "G6", "content": "Consider for vascular prevention"}, {"node": "G7", "content": "Antiischemic agents (NTG)"}, {"node": "G8", "content": "Warfarin: If indication for anticoagulation (AF, mural thrombus, etc.)"}, {"node": "G9", "content": "Diabetes: Optimize glycemia"}]}, {"node": "H", "content": "Psychosocial", "children": [{"node": "H1", "content": "Assessment and treatment of depression/anxiety"}, {"node": "H2", "content": "Assessment of overall prognosis and patient's values with regard to goals of therapy"}]}, {"node": "I", "content": "Behavioral", "children": [{"node": "I1", "content": "Diet plan/ nutrition referral"}, {"node": "I2", "content": "Smoking cessation plan"}, {"node": "I3", "content": "Exercise plan/ cardiac rehabilitation"}, {"node": "I4", "content": "Supervised exercise program for moderate- to high-risk patients"}, {"node": "I5", "content": "Supervised rehabilitation program may enhance education and exercise for all patients"}, {"node": "I6", "content": "Symptom-limited ETT at 3\u20136 wk after MI prior to formal exercise program"}, {"node": "I7", "content": "Maintain activity \u22645 METS until 3-6 wk follow-up with physician \u00b1 symptom-limited ETT"}]}]}]}